• Explore /
  • Poster
  • / RAINBOW-Asia: A randomized, multicenter, double-blind, phase III study of ramucirumab plus paclitaxel versus placebo plus paclitaxel in the treatment of advanced gastric or gastroesophageal junction (GEJ) adenocarcinoma following disease progression on first-line chemotherapy with platinum and fluoropyrimidine.

RAINBOW-Asia: A randomized, multicenter, double-blind, phase III study of ramucirumab plus paclitaxel versus placebo plus paclitaxel in the treatment of advanced gastric or gastroesophageal junction (GEJ) adenocarcinoma following disease progression on first-line chemotherapy with platinum and fluoropyrimidine.

Abstract Poster

Authors

Rui-Hua Xu

Rui-hua Xu

Sun Yat-sen University Cancer Centre, Guangzhou, China

Rui-hua Xu , Yan-Qiao Zhang , Hongming Pan , Ji Feng Feng , Tao Zhang , Tianshu Liu , Yanru Qin , Rubing Han , Wanli Zhang , Lin Shen

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2021 Gastrointestinal Cancers Symposium

Session Type

Poster Session

Session Title

Poster Session: Esophageal and Gastric Cancer

Track

Esophageal and Gastric Cancer

Sub Track

Therapeutics

Clinical Trial Registration Number

NCT02898077

Citation

J Clin Oncol 39, 2021 (suppl 3; abstr 199)

DOI

10.1200/JCO.2021.39.3_suppl.199

Abstract #

199

Poster Bd #

Online Only

Abstract Disclosures

Similar Posters

First Author: Kei Muro

First Author: Salah-Eddin Al-Batran

First Author: Federica Morano

First Author: Daisuke Sakai